← Open Payments lookup

MICHELLE REED: Open Payments

NPI 1043753973 · READING, PA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$4,019 in 120 payments from 11 companies in 2025. Trend: 2023 $565 · 2024 $2,736 · 2025 $4,019

Food & beverage: $4,000Education: $19
CompanyPaymentsAmount
ABBVIE INC.19$656
Alkermes, Inc.13$610
Axsome Therapeutics, Inc.8$478
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)9$469
E.R. Squibb & Sons, L.L.C.9$381
Teva Pharmaceuticals USA, Inc.22$369
Neurocrine BioSciences, Inc.5$304
Otsuka America Pharmaceutical, Inc.9$263
Janssen Pharmaceuticals, Inc12$222
Vanda Pharmaceuticals Inc.8$157

Products named: VRAYLAR, Auvelity, CAPLYTA, COBENFY, REXULTI, INGREZZA, ARISTADA, LYBALVI.

Industry payments across PA — which companies pay providers there.